IMPACT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NASAL PCR ON VANCOMYCIN USE IN PNEUMONIA

被引：0
|
作者：
Kantharia, Shivani [1 ]
Veve, Michael
Mulugeta, Surafel [2 ]
Beaulac, Amy [2 ]
Vincent, Shaina [2 ]
Patel, Nisha [2 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
[2] Henry Ford Hosp, Detroit, MI USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
522
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia
    Scheetz, MH
    Wunderink, RG
    Postelnick, MJ
    PHARMACOTHERAPY, 2006, 26 (04): : 539 - 550
  • [22] Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci
    Nelson, RRS
    LANCET, 1997, 350 (9087): : 1327 - 1327
  • [23] COST-EFFECTIVENESS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NASAL SWABS IN PNEUMONIA
    Kedzior, Sonya
    Minor, Noah
    Molina, Kyle
    Mueller, Scott
    Miller, Matthew
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 625 - 625
  • [24] Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan
    Wang, JL
    Tseng, SP
    Hsueh, PR
    Hiramatsu, K
    EMERGING INFECTIOUS DISEASES, 2004, 10 (09) : 1702 - 1704
  • [25] VANCOMYCIN THERAPY FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    SORRELL, TC
    PACKHAM, DR
    SHANKER, S
    FOLDES, M
    MUNRO, R
    ANNALS OF INTERNAL MEDICINE, 1982, 97 (03) : 344 - 350
  • [26] Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond
    Holmes, Natasha E.
    Tong, Steven Y. C.
    Davis, Joshua S.
    van Hal, Sebastiaan J.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) : 17 - 30
  • [27] Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
    Tian Ye
    Huang Xu
    Wu Li-Juan
    Yi Li
    Li Min
    Gu Si-Chao
    Guo Dong-Jie
    Zhan Qing-Yuan
    中华医学杂志英文版, 2018, 131 (16)
  • [28] Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
    Tian, Ye
    Huang, Xu
    Wu, U-Juan
    Yi, Li
    Li, Min
    Gu, Si-Chao
    Guo, Dong-Jie
    Zhan, Qing-Yuan
    CHINESE MEDICAL JOURNAL, 2018, 131 (16) : 2002 - 2004
  • [29] Linezolid Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: Controversy Continues
    Masuta, Kana
    Oba, Yuichiro
    Iwata, Kentaro
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 161 - 161
  • [30] Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia -: The subtleties of subgroup analyses
    Powers, JH
    Ross, DB
    Lin, D
    Soreth, J
    CHEST, 2004, 126 (01) : 314 - 315
12345